Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world byimproving access to proven treatments for various diseases.

$3.8B

Market Cap • 12/25/2024

2018

(6 years)
Founded

2022

(2 years ago)
IPO

NASDAQ

Listing Exchange
Flag of LU

Luxembourg

Headquarters

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions
  • ...and much more!

    Get Premium